Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-09

Clinical Trial Update: Tranexamic Acid Dosing for Major Joint Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on tranexamic acid dosing for major joint replacement surgery (knee and hip arthroplasty) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip | Phase 2 | Status: COMPLETED | Results posted: 2025-12-09